American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about SG Americas Securities LLC Purchases Shares of 122,716 IonQ, Inc. (NYSE:IONQ)

SG Americas Securities LLC Purchases Shares of 122,716 IonQ, Inc. (NYSE:IONQ)

SG Americas Securities LLC purchased a new stake in IonQ, Inc. (NYSE:IONQ – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm purchased 122,716 shares of the company’s stock, valued at approximately... More of this article »
Image about Raymond James & Associates Sells 188 Shares of EMCOR Group, Inc. (NYSE:EME)

Raymond James & Associates Sells 188 Shares of EMCOR Group, Inc. (NYSE:EME)

Raymond James & Associates decreased its holdings in EMCOR Group, Inc. (NYSE:EME – Free Report) by 0.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 180,056... More of this article »
Image about Insider Buying: Synopsys, Inc. (NASDAQ:SNPS) Director Purchases 750 Shares of Stock

Insider Buying: Synopsys, Inc. (NASDAQ:SNPS) Director Purchases 750 Shares of Stock

Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) Director Marc N. Casper purchased 750 shares of the company’s stock in a transaction dated Monday, March 25th. The stock was purchased at an average price of $585.45 per share,... More of this article »
Image about CVA Family Office LLC Invests $40,000 in Mid-America Apartment Communities, Inc. (NYSE:MAA)

CVA Family Office LLC Invests $40,000 in Mid-America Apartment Communities, Inc. (NYSE:MAA)

CVA Family Office LLC bought a new position in shares of Mid-America Apartment Communities, Inc. (NYSE:MAA – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 295 shares of the real estate... More of this article »
Image about Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) Shares Sold by Schechter Investment Advisors LLC

Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) Shares Sold by Schechter Investment Advisors LLC

Schechter Investment Advisors LLC decreased its holdings in shares of Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA – Free Report) by 6.6% in the 4th quarter, according to the company in its most recent Form 13F filing with... More of this article »
Image about Orchestra BioMed (NASDAQ:OBIO) Earns Buy Rating from Chardan Capital

Orchestra BioMed (NASDAQ:OBIO) Earns Buy Rating from Chardan Capital

Chardan Capital reissued their buy rating on shares of Orchestra BioMed (NASDAQ:OBIO – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. Chardan Capital currently has a $20.00 price objective... More of this article »
Image about Office Properties Income Trust (NASDAQ:OPI) PT Lowered to $1.60

Office Properties Income Trust (NASDAQ:OPI) PT Lowered to $1.60

Office Properties Income Trust (NASDAQ:OPI – Free Report) had its price objective trimmed by Morgan Stanley from $1.80 to $1.60 in a research report released on Thursday morning, Benzinga reports. The firm currently has an underweight... More of this article »
Image about Neumora Therapeutics’ (NMRA) “Outperform” Rating Reaffirmed at Royal Bank of Canada

Neumora Therapeutics’ (NMRA) “Outperform” Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reaffirmed their outperform rating on shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) in a research report released on Thursday, Benzinga reports. They currently have a $31.00 target price on... More of this article »
Image about Mereo BioPharma Group (NASDAQ:MREO) Stock Rating Reaffirmed by Cantor Fitzgerald

Mereo BioPharma Group (NASDAQ:MREO) Stock Rating Reaffirmed by Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a report released on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $7.00 target price... More of this article »
Image about UBS Group Trims MarketWise (NASDAQ:MKTW) Target Price to $2.00

UBS Group Trims MarketWise (NASDAQ:MKTW) Target Price to $2.00

MarketWise (NASDAQ:MKTW – Free Report) had its price target decreased by UBS Group from $3.50 to $2.00 in a report released on Thursday morning, Benzinga reports. UBS Group currently has a neutral rating on the newsletter publisher’s... More of this article »
Image about Metagenomi (NASDAQ:MGX) Receives Buy Rating from Chardan Capital

Metagenomi (NASDAQ:MGX) Receives Buy Rating from Chardan Capital

Chardan Capital restated their buy rating on shares of Metagenomi (NASDAQ:MGX – Free Report) in a research report released on Thursday, Benzinga reports. Chardan Capital currently has a $21.00 price target on the stock. A number... More of this article »
Image about Lands’ End (NASDAQ:LE) Rating Increased to Buy at Craig Hallum

Lands’ End (NASDAQ:LE) Rating Increased to Buy at Craig Hallum

Craig Hallum upgraded shares of Lands’ End (NASDAQ:LE – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday morning, MarketBeat Ratings reports. The brokerage currently has... More of this article »
Image about Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded to “Sell” by StockNews.com

Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded to “Sell” by StockNews.com

StockNews.com upgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) to a sell rating in a research report sent to investors on Thursday morning. A number of other research analysts have also issued reports on... More of this article »
Image about Limbach (NASDAQ:LMB) Upgraded by StockNews.com to Strong-Buy

Limbach (NASDAQ:LMB) Upgraded by StockNews.com to Strong-Buy

StockNews.com upgraded shares of Limbach (NASDAQ:LMB – Free Report) from a buy rating to a strong-buy rating in a report released on Thursday morning. Limbach Price Performance Limbach stock opened at $41.42 on Thursday. Limbach... More of this article »
Image about Jasper Therapeutics (NASDAQ:JSPR) Earns Outperform Rating from Analysts at Royal Bank of Canada

Jasper Therapeutics (NASDAQ:JSPR) Earns Outperform Rating from Analysts at Royal Bank of Canada

Royal Bank of Canada assumed coverage on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a research report report published on Thursday morning, MarketBeat Ratings reports. The firm issued an outperform rating and... More of this article »